YARROW BIOSCIENCE, INC. Preferred Stock, Accretion of Redemption Discount
YARROW BIOSCIENCE, INC. (YARW) reported Preferred Stock, Accretion of Redemption Discount of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2025-03-06
- YARROW BIOSCIENCE, INC. preferred stock, accretion of redemption discount for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- YARROW BIOSCIENCE, INC. preferred stock, accretion of redemption discount for fiscal 2023 was $149.00K.
- YARROW BIOSCIENCE, INC. preferred stock, accretion of redemption discount for fiscal 2022 was $0.00.
| Period end | Preferred Stock, Accretion of Redemption Discount 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2023-12-31 | $149.00K 10-K · filed 2025-03-06 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |